title: Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment.
abstract: We evaluated the prevalence of antithyroid peroxidase antibodies (anti-TP0 Ab) in 402 patients with thyroid disease and 30 healthy controls by a commercial radioimmunoassay (RIA) and compared the results with the passive hemagglutination (HA) method. The patients in the study had autoimmune thyroid disorders (AITD) such as Graves' disease and Hashimoto's disease or had nonautoimmune thyroid diseases (NAITD) such as thyroid cancer, congenital goiter, endemic goiter, and nodular goiter. Subjects were recruited from a population with a mild iodine deficiency (Sao Paulo, Brazil). The effect of specific therapy (for either thyrotoxicosis or chronic thyroiditis) on the circulating anti-TPO levels was also investigated. Positive anti-TPO Ab was detected in 89.9% of the patients with AITD as compared with a prevalence of positive tests of only 4.8% in patients with NAITD. Positive microsomal antibody (M Ab) was found in 68.4% of the patients with AITD and in 6.4% of the patients with NAITD. A positive and significant correlation was obtained between M Ab and anti-TPO Ab. A positive anti-TPO test with negative anti-M was found in 14.1% of the patients with AITD but in only 4.3% of the patients with NAITD and normal controls. These results suggest that anti-TPO Ab by RIA is more sensitive and specific than M Ab by HA. In patients with AITD, anti-TPO Ab levels usually decreased after treatment, suggesting that this parameter could be used in the follow-up of these thyroid disorders.
authors.affiliation: Thyroid Laboratory, Hospital das Clínicas, University of Sao Paulo Medical School, Brazil.
authors.forename: M
authors.initials: M
authors.lastname: Knobel
authors.forename: M F
authors.initials: MF
authors.lastname: Barca
authors.forename: F
authors.initials: F
authors.lastname: Pedrinola
authors.forename: G
authors.initials: G
authors.lastname: Medeiros-Neto
mesh_terms: D000918:Antibody Specificity; D001323:Autoantibodies / Q000032:analysis* / Q000276:immunology; D001938:Brazil / Q000453:epidemiology; D006042:Goiter / Q000151:congenital / Q000453:epidemiology / Q000276:immunology; D006043:Goiter, Endemic / Q000453:epidemiology / Q000276:immunology; D006044:Goiter, Nodular / Q000453:epidemiology / Q000276:immunology; D006111:Graves Disease / Q000453:epidemiology / Q000276:immunology; D006386:Hemagglutination Tests; D006801:Humans; D007453:Iodide Peroxidase / Q000276:immunology*; D007455:Iodine / Q000172:deficiency*; D011863:Radioimmunoassay; D013959:Thyroid Diseases / Q000453:epidemiology / Q000276:immunology*; D013964:Thyroid Neoplasms / Q000453:epidemiology / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000453:epidemiology / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D007455:Iodine; D007453:Iodide Peroxidase